https://birminghamdaily.co.uk/tags/headandneck/Recent content in headandneck on Birmingham DailyHugo -- gohugo.ioen-usMon, 01 Jun 2026 04:45:00 +0000https://birminghamdaily.co.uk/birmingham-cancer-patient-shares-life-changing-impact-of-new-drug-amivantamab/Mon, 01 Jun 2026 04:45:00 +0000https://birminghamdaily.co.uk/birmingham-cancer-patient-shares-life-changing-impact-of-new-drug-amivantamab/A groundbreaking clinical trial led by the Institute of Cancer Research (ICR) in London has revealed “unprecedentedly strong responses” to a new injectable drug, amivantamab, which has eliminated entire tumors in patients with recurrent or metastatic head and neck cancer that had stopped responding to conventional treatments. The international study found that 42% of patients experienced significant tumor shrinkage, with 15 participants seeing complete tumor disappearance. The trial included 102 individuals whose cancers had progressed despite chemotherapy and immunotherapy, highlighting amivantamab’s potential to benefit a group of patients with very limited options.